Standard- and Micro-Dose rhBMP-2 for Implant Stability, Marginal Bone Loss, and Postoperative Sequelae: A Double-Blind Randomized Controlled Trial

NCT07696299 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Tooth Loss / Rehabilitation
Dental Implant
Osseo-Integrated Implants

Interventions

BIOLOGICAL: Standard-dose rhBMP-2
BIOLOGICAL: Micro-dose rhBMP-2
DRUG: Sterile Normal Saline

Sponsor

University of Baghdad